World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
8618
World Ranking
4003
National Ranking
352

Lindy G. Durrant publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lindy G. Durrant sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 230 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lindy G. Durrant D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lindy G. Durrant sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lindy G. Durrant is affiliated with the University of Nottingham in the United Kingdom. Their research spans multiple intersecting fields within biomedical sciences, predominantly focusing on medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. The scientist's work is often situated within subfields such as immunology, oncology, molecular biology, genetics, and cell biology.

Their scholarly contributions include research on cancer immunotherapy and immune responses as well as glycosylation and glycoproteins. Specific topics explored by Durrant include immunotherapy and immune responses, cancer immunotherapy and biomarkers, glycosylation and glycoproteins research, CAR-T cell therapy research, peptidase inhibition and analysis, vaccines and immunoinformatics approaches, and RNA interference and gene delivery.

Frequent co-authors collaborating with Durrant are:

  • Victoria A. Brentville
  • Mireille Vankemmelbeke
  • Samantha Paston
  • Peter Symonds
  • Rachael L. Metheringham

Durrant has published numerous papers in prominent scientific journals. Frequent publication venues include:

  • Frontiers in Immunology
  • Journal for ImmunoTherapy of Cancer
  • Cancer Research
  • Scientific Reports
  • Cancers

Selected recent papers authored or co-authored by Lindy G. Durrant include:

  • Cancer Vaccines, Adjuvants, and Delivery Systems, 2021, Frontiers in Immunology
  • Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment, 2020, Frontiers in Immunology
  • Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses, 2020, Journal for ImmunoTherapy of Cancer
  • Post-translational modifications such as citrullination are excellent targets for cancer therapy, 2020, Seminars in Immunology
  • Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus, 2020, Scientific Reports

Best Publications

  • Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

    Nicholas F.S. Watson;Judith M. Ramage;Zahra Madjd;Ian Spendlove

  • Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

    Ekaterina S. Jordanova;Arko Gorter;Ouissam Ayachi;Frans Prins

  • Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer

    Jonathan A D Simpson;Ahmad Al-Attar;Nicholas F S Watson;John H Scholefield

  • NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting

    Roger W. McGilvray;Robert A. Eagle;Nicholas F.S. Watson;Ahmad Al-Attar

  • Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients

    Nicholas F.S. Watson;Nicholas F.S. Watson;Ian Spendlove;Zahra Madjd;Roger McGilvray

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

    Zahra Madjd;Ian Spendlove;Sarah E. Pinder;Ian O. Ellis

  • Cancer Vaccines, Adjuvants, and Delivery Systems.

    Samantha J. Paston;Victoria A. Brentville;Peter Symonds;Lindy G. Durrant

  • The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin.

    S. A. Watson;L. G. Durrant;J. D. Crosbie;D. L. Morris

  • Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?

    Timothy J. Duncan;Ahmad Al-Attar;Phil Rolland;Ian V. Scott

  • Gastrin: growth enhancing effects on human gastric and colonic tumour cells.

    S Watson;L Durrant;D Morris

  • CD55 is over-expressed in the tumour environment

    L Li;I Spendlove;J Morgan;L G Durrant

  • The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease

    Phil Rolland;Zahra Madjd;Lindy Durrant;Ian O Ellis

  • Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.

    V S Byers;R Rodvien;K Grant;L G Durrant

  • Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients

    L. G. Durrant;M. A. Chapman;D. J. Buckley;I. Spendlove

  • High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.

    Zahra Madjd;Tina Parsons;Nicholas F S Watson;Ian Spendlove

  • Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro.

    S. A. Watson;L. G. Durrant;D. L. Morris

  • The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

    A Popple;L G Durrant;I Spendlove;P Rolland

  • Costimulation via CD55 on Human CD4 + T Cells Mediated by CD97

    Melania Capasso;Lindy G. Durrant;Martin Stacey;Siamon Gordon

  • Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients.

    Gustave J. Ullenhag;Abhik Mukherjee;Nicholas F.S. Watson;Ahmad H. Al-Attar

Frequent Co-Authors

Robert W. Baldwin
Robert W. Baldwin University of Nottingham
Ian O. Ellis
Ian O. Ellis University of Nottingham
Uwe Aickelin
Uwe Aickelin University of Melbourne
David L. Morris
David L. Morris University of New South Wales
Sarah E Pinder
Sarah E Pinder King's College London
Robert C. Rees
Robert C. Rees Nottingham Trent University
Andrew R. Green
Andrew R. Green University of Nottingham
Christian H. Ottensmeier
Christian H. Ottensmeier University of Southampton
Guoping Qiu
Guoping Qiu University of Nottingham
Dileep N. Lobo
Dileep N. Lobo University of Nottingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open diverse career opportunities in healthcare and research. Many students interested in clinical applications explore advanced nursing programs, which complement their scientific background. For those seeking flexible options, nurse practitioner programs with easy admission offer accessible entry points that help working professionals advance their qualifications without sacrificing time.

Mental health is a critical area where immunological knowledge intersects with clinical practice. Programs like the best pmhnp programs online provide specialized training in psychiatric mental health nurse practitioner roles, often combined with robust clinical placement opportunities. For those mindful of education costs, exploring the cheapest psychiatric nurse practitioner programs can make advanced degrees more attainable.

Career outcomes in nursing, such as the Doctor of Nursing Practice (DNP), are promising. Understanding the doctor of nursing practice salary by state helps graduates make informed decisions when choosing where to study or practice. Combining immunology with nursing practice enriches patient care and broadens career possibilities.

Best Scientists Citing Lindy G. Durrant

Trending Scientists

Recently Published Articles